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The purpose of this study was to determine whether levels of interleukin-6 (IL-6) in childhood are related to insulin resistance in
adolescence. Further, to explore how fatness and cardiorespiratory ﬁtness (VO2peak) moderate this relationship. Methods. 292 nine-
year-old children (n = 292) were followed for 4 years. Anthropometrics and VO2peak were measured. Fasting blood samples were
analyzed for IL-6, insulin, and glucose. Homeostasis model assessment (HOMA-IR) was used as a measure of insulin resistance.
Results. For girls but not boys, levels of IL-6 at age 9yrs correlated with HOMA-IR at age 13yrs: r = 0.223, P = 0.008. Girls
with IL-6 levels within the highest quartile at age 9yrs had an odds ratio of 3.68 (CI = 1.58–8.57) being in the highest quartile of
HOMA-IR four years later. Conclusion. In this cohort, IL-6 levels in childhood were related to insulin resistance in adolescence,
but only for girls.
1.Background
It is well established that increased levels of fatness are asso-
ciated with low-grade inﬂammation in adults [1, 2], as well
as in children [3]. Low-grade inﬂammation has been pro-
posed as a mechanism linking obesity with systemic compli-
cations such as insulin resistance and type 2 diabetes [4, 5].
Among the inﬂammatory markers, IL-6 has emerged as
one of the potential mediators between obesity and insulin
resistance/diabetes [6–8]. However, reports have suggested
both pro- and anti-inﬂammatory eﬀects of IL-6 [9, 10]. IL-6
is a cytokine produced in various tissues including adipose
tissue, muscle tissue, and immune cells. Resting, circulating
levels of IL-6 have been found positively related to fatness
[7, 11] and negatively related to the level of ﬁtness and
physical activity [12].
Thecross-sectionalrelationshipbetweenIL-6andinsulin
resistance in youth has been investigated, but no relationship
hasbeenfound[13–16].Onelongitudinalstudy,investigated
the eﬀect of a weight loss program on inﬂammatory markers
in obese children [17]. They found a weak but signiﬁcant
correlation between change scores of IL-6 and HOMA-IR
overoneyear.Toourknowledge,nostudieshaveinvestigated
the longitudinal relation between IL-6 and HOMA over
thecourse of childhood and early adolescence in a normal
pediatric population. Therefore, the aim of the present study
wastoevaluateassociationsbetweenIL-6andHOMA-IRina
longitudinal design, following children through early adoles-
cence. Furthermore, we aimed at exploring whether fatness
or VO2peak moderate these relationships. We hypothesized
that in a normal pediatric population (1) a high level of IL-6
in childhood is, not was related to an elevated HOMA-IR in2 Experimental Diabetes Research
adolescence and (2) a high level of IL-6 in childhood tracks
into adolescence.
2. Methods
2.1. Participants. All children in kindergarten classes (6-7
years of age) from 2 suburbs of Copenhagen, Denmark, were
invited to participate in a 3-year, controlled intervention
study of physical activity and health: the Copenhagen School
Child Intervention Study. Data were collected at baseline,
following the intervention, and 4years after the intervention.
The study has been described in details elsewhere [18, 19].
Data used in this paper is from the postintervention
measurement in 2003/2004 (age 9yrs) and the follow-up
measurement in 2008 (age 13yrs). Complete data on IL-6
from both assessments were available for 292 subjects. Since
no diﬀerences between IL-6 levels in the intervention and
control group were found, data from the two groups were
pooled for all analyses.
2.2. Ethics. The ethical committee of Copenhagen approved
the study. Written informed consent was obtained from the
parents/guardians.
2.3. Measurements. Tests were performed at all 18 schools
in the two communities. Fitness test was performed in a
mobile unit, and all other tests were performed in a gym
or a classroom between 8:00 AM and 02:00 PM. Fasting
blood samples were collected before 10 AM. Body mass was
measured to the nearest 0.1kg (Seca 882, Brooklyn, NY).
Body height was measured to the nearest 1mm in bare feet
(Harpendenstadiometer,WestSussex,UK).Bodymassindex
(BMI)wascalculatedasweightmultipliedbyheightsquared.
Skinfolds (biceps, triceps, subscapular and suprailiac) were
measured to the nearest mm with caliper (Harpenden, West
Sussex, UK) according to criteria presented by De Lorenzo
and coworkers [20]. The mean of 3 measurements was used
for subsequent analysis. The sum of four skinfolds (S4SF)
was calculated and used as an estimate of body fatness [21].
Waist circumference was measured at the end of a nor-
mal expiration, midway between the lower rib margin and
the anterior iliac crest. Sexual maturation was assessed by
self-report using a scale of pictures of breast and genital
development for girls and boys, respectively [22]. 5 boys
and one girl were unwilling to have their sexual maturation
assessed.
Blood samples were collected in the morning after a
minimum of 8 hours veriﬁed fasting. Children did not
have their blood drawn if they suﬀered from any infectious
disease or had fever. Samples were immediately analyzed for
glucose (Hemocue, Sweden). The rest of the samples were
centrifuged, and the plasma was initially frozen at −20◦C
and then stored at −80◦C the same day. Insulin was analyzed
using an enzyme-linked immunosorbent assay (DAKO
Insulin, Code no. K6219; DAKO, Glostrup, Denmark).
Homeostasis model assessment (HOMA-IR) was used as an
estimate of insulin resistance [23]: ([glucose (mmol·L−1) ×
insulin (mU·L−1)]/22.5). IL-6 was analyzed with high-
sensitivity immunoassays (Quantikine High-Sensitivity EL-
ISA)withadetectionlimitof0.5pg·mL−1 (R&D,Minneapo-
lis, MN). Cardiorespiratory ﬁtness (VO2peak) was measured
during a progressive treadmill running test until exhaustion.
VO2peak was measured using an AMIS 2001 Cardiopul-
monaryFunctionTestSystem(Innovision,DK5260Odense)
at age 9yrs and using the COSMED K4b2 portable metabolic
system (COSMED, Rome, IT) at age 13yrs. Both systems
h a v eb e e nf o u n dt og i v er e l i a b l em e a s u r e so fV O 2 uptake,
when validated against the Douglas bag method [24, 25]. For
a test to be valid, at least one of three objective physiological
criteria should be fulﬁlled; heart rate higher than 200
beats/min, respiratory exchange ratio equal to or higher than
1.00, or a plateau of VO2 deﬁned as an increase of less than
2.1mL·min−1·kg−1 [26]. Moreover, the test leader should
subjectively consider the child exhausted. If a child ran to
exhaustion, but did not attain a valid measurement only
because of equipment failure, we estimated VO2peak from
running time to exhaustion and sex in a regression equation
using all the valid measurements, as earlier reported [19].
Approximately 10% of children had their VO2peak calculated.
2.4. Data Analysis. Means and standard deviations for all
variables were computed by sex for descriptive purposes.
BMI, waist circumference, S4SF, HOMA-IR, and IL-6 were
positivelyskewedandthereforetransformed(naturallog)for
the analyses. Independent samples t-tests were used to test
for diﬀerences between sexes.
Pearson correlations were used for longitudinal bivariate
associations between IL-6 at age 9 yrs and HOMA-IR at
age 13 yrs, adjusting for HOMA-IR at age 9yrs. Then, in a
stepwise fashion the correlation were adjusted for (1) S4SF
(2) ﬁtness, and (3) both S4SF and ﬁtness at age 13yrs.
Subsequently, children were divided into groups based on
their maturation (Tanner stages 1–3 and 4-5), and the
correlations were performed stratiﬁed for this variable. To
further explore the data, logistic regression was performed.
The children were divided into sex-speciﬁc quartiles of
HOMA-IR and IL-6 for the logistic regression. Odds ratios
were calculated for being in the upper quartiles of IL-6
and HOMA-IR at age 13yrs, based on being in the upper
quartile of IL-6 at age 9yrs, compared to the three lower
quartiles. The analyses of HOMA were adjusted for HOMA
at age 9 yrs to account for any diﬀerences already present
at baseline. Finally, cross-sectional correlations between IL-
6 and HOMA-IR both at age 9yrs and at age 13yrs were
assessed and adjusted for (1) S4SF, (2) ﬁtness, and (3) S4SF
and ﬁtness. All analyses were performed using the statistical
packageforthesocialsciencesversion15(SPSS,Chicago,IL).
3. Results
The general characteristics of the samples at the age of 9 and
13 yrs are presented by sex in Table 1. Generally, boys were
slightly older and taller than girls and had a greater waist
circumference (P<0.05). Boys had a greater aerobic ﬁtnessExperimental Diabetes Research 3
Table 1: Characteristics of participants by sex and age: mean and standard deviation.
Variables
Boys Girls
9 years 13 years 9 years 13 years
Age (years) 9.6 (0.4) 13.4 (0.3) 9.5 (0.3) 13.3 (0.3)
Height (cm)∗ 140.6 (5.7) 164.9 (8.0) 138.8 (6.8) 162.2 (6.8)
Weight (kg) 33.7 (6.0) 51.7 (10.0) 32.7 (6.1) 50.5 (8.5)
BMI (kg·m−2) 17.0 (2.2) 18.9 (2.7) 16.9 (2.2) 19.2 (2.6)
Normal weight/overweight/obese (%) 88.1/9.9/2.0 88.7/9.3/2.0 87.2/12.1/0.7 90.7/9.3/0.0
Waist circumference (cm)∗ 62.1 (6.3) 68.3 (7.0) 60.6 (6.2) 65.7 (5.4)
Sum of four skinfolds (mm)∗ 27.5 (12.5) 31.2 (17.8) 33.8 (15.8) 37.4 (15.6)
Tanner stages (1–5) 1.1 (0.2) 3.4 (0.8) 1.4 (0.6) 3.8 (0.8)
Aerobic ﬁtness (mL·kg−1·min−1)∗ 53.4 (6.8) 53.0 (7.9) 47.6 (5.9) 45.7 (7.2)
IL-6 (pg·mL−1) 0.8 (1.0) 0.6 (0.5) 1.1 (1.3) 0.8 (1.4)
HOMA score∗ 1.2 (0.6) 2.5 (1.4) 1.3 (0.7) 2.9 (1.5)
∗P<0.05, girls versus boys.
Table 2: Pearson correlations between IL-6 at age 9 yrs and IL-6 and HOMA-IR at age 13 yrs, (1) unadjusted, (2) adjusted for sum of 4
skinfolds (S4SF), (3) VO2peak (mL/kg), and (4) both S4SF and VO2peak at age 13 yrs.
Risk factors age 13yrs
IL-6 age 9 yrs
Unadjusted Adjusted for S4SF Adjusted for VO2peak Adjusted for S4SF & VO2peak
IL-6
Boys 0.130 0.138 0.136 0.133
Girls 0.360∗ 0.349∗ 0.402∗ 0.388∗
HOMA-IRa
Boys 0.053 0.065 0.044 0.055
Girls 0.223∗ 0.199∗ 0.223∗ 0.211∗
∗P value < 0.04. Signiﬁcant correlations in bold face.
a adjusted for HOMA age 9 yrs.
Table 3:PearsoncorrelationsbetweenIL-6atage9yrsandIL-6and
HOMA-IR at age 13yrs in groups based on sexual maturation and
adjusted for HOMA age 9 yrs.
nr
Boys Tanner stages 1–3 83 0.006
Tanner stages 4-5 63 0.107
Girls Tanner stages 1–3 41 0.286†
Tanner stages 4-5 99 0.218∗
Signiﬁcant correlations in bold face. ∗P value = 0.031. †P value = 0.077,
borderline signiﬁcant.
and lower S4SF (both P<0.001), as well as lower HOMA-
IR (P<0.02), compared to girls. At ages 9 and 13yrs, the
girls were on average ∼0.4 Tanner stages ahead of the boys
(P<0.001).
Relationships between circulating IL-6 levels at age 9yrs
and IL-6 and HOMA-IR at age 13yrs are presented in
Table 2. A signiﬁcant correlation was found between levels
of IL-6 at age 9 yrs and at age 13yrs for the girls, but not for
the boys. Furthermore, the girls also displayed correlations
between IL-6 levels at age 9yrs and HOMA-IR four years
later. These correlations were weakened after adjusting for
fatness, and ﬁtness and fatness combined at age 13yrs.
Table 4:RiskofhighIL-6andHOMA-IRlevelinadolescencebased
on IL-6 level in childhood.
95% conﬁdence
Odds ratio Interval P value
IL-6 at age 13
Boys 0.90 0.38–2.12 0.81
Girls 2.55 1.12–5.80 0.03
HOMA-IR at age 13a
Boys 0.93 0.39–2.22 0.87
Girls 3.68 1.58–8.57 0.003
Odds ratios for being in the highest quartile of CVD risk factors age 13yrs
according to being in the upper quartile of IL-6 at age 9yrs. Signiﬁcant odds
ratios are presented in bold.
a: adjusted for HOMA at age 9yrs.
Table 3 shows these correlations stratiﬁed by Tanner stages.
Only the most mature girls (Tanner stages 4-5) displayed a
signiﬁcant correlation between IL-6 levels at age 9yrs and
HOMA-IR at age 13yrs.
Logistic regression was performed to assess the risk
of ending up in the highest quartile of HOMA-IR at age
13yrs after having had systemic IL-6 levels within the upper
quartileatage9yrs.TheresultsarepresentedinTable 4.Girls4 Experimental Diabetes Research
with IL-6 levels within the upper quartile at age 9yrs had an
odds ratio of 2.55 for having IL-6 levels within the upper
quartile at age 13yrs and an odds ratio of 3.86 for being
in the upper quartile of HOMA-IR, compared with the rest
of the girls. There were no other signiﬁcant increased risks
(P>0.05).
There were no signiﬁcant cross-sectional correlations
between IL-6 levels and HOMA-IR at age 9 yrs or at age
13yrs, irrespective of adjustment for fatness and ﬁtness.
HOMA age 9yrs was correlated with HOMA age 13yrs for
girls (r = 0.242, P = 0.004), but not for boys (r = 0.143,
P = 0.083).
4. Discussion
To our knowledge this is the ﬁrst study to examine the
longitudinal relation between IL-6 and HOMA-IR in a
normal pediatric population. A correlation was observed
between circulating IL-6 levels at age 9yrs and HOMA-IR
at age 13yrs for girls, but not for boys. In support of a
longitudinal relationship between IL-6 and HOMA-IR, Roth
and colleagues found a weak but signiﬁcant correlation
between change scores of IL-6 and HOMA-IR over one year
in an intervention study on obese children [17]. This result,
together with our ﬁnding in girls, could suggest a role of
IL-6 in the longitudinal development of insulin resistance.
However, we did not ﬁnd any correlations between IL-6 and
HOMA-IR in the cross-sectional analyses, in accordance
with ﬁndings of other cross-sectional studies on IL-6 and
insulin level or HOMA-IR in youth [13–15, 27].
The speciﬁc role of IL-6 in the pathogenesis of insulin
resistance is still controversial. It has been shown that IL-6
suppresses the production of TNF-α, a cytokine involved
in the pathogenesis of insulin resistance and CVD [10].
Concomitantly, TNF-α causes IL-6 production and release
of IL-6 to the circulation [9]. Therefore, hypothetically it
is possible that TNF-α actually induces impaired glucose
metabolism, while high systemic levels of IL-6 reﬂect a high
local production of TNF-α and are not directly involved in
the pathogenesis of insulin resistance [9]. Unfortunately, we
were not able to include other measures of low-grade inﬂam-
mation, for example, TNF-α, TNF-modifying mediators, or
CRP in this study, which makes it impossible for us to make
any interpretations regarding the mechanisms by which low-
grade inﬂammation inﬂuence the development of insulin
resistance. Our ﬁndings should therefore just be interpreted
as descriptive.
Body fat is related to HOMA-score [28], as well as to
systemic IL-6 levels in some studies of pediatric populations
[16, 29–31], but not all [14, 17, 27, 32]. Fatness could
therefore potentially inﬂuence the relation between IL-6 and
HOMA-IR. Adjusting for S4SF at age 13yrs weakened the
correlation found in girls between IL-6 at age 9yrs and
HOMA-IR at age 13yrs in this study, but systemic IL-6
levels remained as an independent predictor of high HOMA-
IR at age 13yrs. A study by Tam and colleagues found no
signiﬁcant diﬀerences in IL-6 level between normal weight
a n do v e r w e i g h t / o b e s eg r o u p sa ta g e8y r s ,b u tw h e nf o l l o w e d
up at age 15 yrs, overweight/obese girls had signiﬁcantly
higher levels of IL-6, compared to normal-weight girls. No
diﬀerences were seen for boys [33]. This study supports our
ﬁnding of a sex diﬀerence in relation to IL-6, which has also
been found in studies on adult populations [34, 35]. Fur-
thermore,theirresults,togetherwithourresults,suggestthat
in girls elevated IL-6 production develops over a prolonged
period of time and is, possibly, inﬂuenced by sexual matu-
ration or estrogens. The girls in our study were on average
0.4 tanner stages ahead of the boys at the same age (Table 1),
which may account for some of the sex diﬀerences we found
in the relations between IL-6 and HOMA-IR. When the girls
in our study were split into groups of maturation stages
(Tanner stages 1–3 and Tanner stages 4-5), only the mature
girls displayed a signiﬁcant correlation between IL-6 and
HOMA-IR (Table 3). However, this diﬀerence in signiﬁcant
ﬁndings between sexual maturation groups was probably
caused by a lack of power due to the small sample size in the
less mature group. Actually, the correlation coeﬃcient in the
less mature group was higher compared to the more mature.
In the present study, adjustment for VO2peak did not
alter the correlations between IL-6 and HOMA-IR. Likewise,
Rubin et al. did not ﬁnd any eﬀect of adjusting for maximal
aerobic power in the association between HOMA-IR and
IL-6 [13]. Other studies have investigated the relationship
between IL-6 and ﬁtness in youth and did not ﬁnd any
correlation [15, 16].
Themainstrengthofthepresentstudyisthelongitudinal
design with a four-year period between the two measure-
ments.Toourknowledge,nootherresearchershavefollowed
children for this length of time. One limitation of this study
is the low number of overweight and obese individuals
in the study population and low mean values for both
HOMA-IRandIL-6levels(Table 1).However,wehaveearlier
reported that in this cohort ∼14% of the children had an
adverse CVD risk proﬁle at age 9 yrs [36]. Also, we did
not include other inﬂammatory markers, for example, TNF-
α and TNF-modifying mediators in this study, thus we
cannot exclude that some confounders related to both IL-
6 and insulin resistance are aﬀecting the associations we
investigated. Therefore, no conclusions regarding the mech-
anisms by which low-grade inﬂammation aﬀect insulin
resistance can be drawn. Future studies could therefore focus
on other inﬂammatory markers more closely related to the
pathogenicprocessesinyouth,forexample,CRPandTNF-α.
Furthermore, a more diverse population including a higher
number of overweight and obese children and more children
with adverse health outcomes could strengthen the scientiﬁc
impact of the results. Also the genetic aspects in the relation
between low-grade inﬂammation and the pathogenesis of
insulin resistance should be investigated in future studies.
Finally, we did not control for exercise immediately prior
to blood sampling. However, blood sampling was done
early in the morning, and it was not likely that any of
the children had performed prolonged exercise prior to
sampling. Furthermore, although we excluded children with
any signs of infections or fever, undetected subclinical
infection could have caused an increase in IL-6 levels in
some children. We did, however, try to run all analysesExperimental Diabetes Research 5
omitting outliers and that did not change our results sub-
stantially.
In conclusion, the results of this study show that IL-6
levelsinchildhoodtrackintoadolescence,especiallyforgirls.
Further, IL-6 levels in childhood are related to HOMA-IR
four years later for girls, but not for boys. These relationships
remained signiﬁcant after adjusting for fatness and ﬁtness.
We did not ﬁnd any cross-sectional association between IL-6
and HOMA-IR at either age 9 or age 13 yrs, suggesting that






HOMA-IR: Homeostatic model assessment
CRP: C-reactive protein
TNF-α: Tumor necrosis factor-α
BMI: Body mass index
S4SF: The sum of four skinfolds.
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